TechnipFMC (NYSE: FTI) executive sells 116,194 shares after option exercises

Rhea-AI Filing Summary

TechnipFMC plc President, Subsea Jonathan Landes reported multiple equity transactions in Ordinary Shares on March 9, 2026. He exercised employee stock options for 7,317 shares at an exercise price of $25.24 and 10,873 shares at $21.10, acquiring a total of 18,190 shares.

On the same date, Landes sold 31,568 shares at a weighted average price of $61.26, 48,559 shares at $62.13, and 36,067 shares at $63.13, for total open‑market sales of 116,194 shares. He also made a bona fide gift of 20,768 shares at no consideration. Following these transactions, he directly holds 50,588 Ordinary Shares.

All sales and option exercises were effected pursuant to a Rule 10b1-5 trading plan adopted by Landes on December 3, 2025, indicating the trades were pre‑scheduled rather than discretionary.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Landes Jonathan

(Last) (First) (Middle)

C/O TECHNIPFMC PLC

HADRIAN HOUSE, WINCOMBLEE ROAD

(Street)

NEWCASTLE UPON TYNE X0 NE6 3PL

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TechnipFMC plc [ FTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Subsea

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/09/2026		M		7,317(1)	A	$25.24	176,677	D
Ordinary Shares	03/09/2026		M		10,873(1)	A	$21.1	187,550	D
Ordinary Shares	03/09/2026		S		31,568(1)	D	$61.26(2)	155,982	D
Ordinary Shares	03/09/2026		S		48,559(1)	D	$62.13(3)	107,423	D
Ordinary Shares	03/09/2026		S		36,067(1)	D	$63.13(4)	71,356	D
Ordinary Shares	03/09/2026		G		20,768	D	$0	50,588	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$25.24	03/09/2026		M			7,317(1)(5)	02/26/2021	06/14/2028	Ordinary Shares	7,317	$0	0	D
Employee Stock Option (right to buy)	$21.1	03/09/2026		M			10,873(1)(5)	02/28/2020	06/26/2027	Ordinary Shares	10,873	$0	0	D

Explanation of Responses:

1. The transactions reported in this Form 4 (all sales and the exercise of stock options) were effected pursuant to a Rule 10b1-5 trading plan adopted by the Reporting Person on December 3, 2025.

2. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $61.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.68 to $62.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.68 to $63.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. Reflects the automatic adjustment of the exercise price and number of shares subject to the employee stock option pursuant to anti-dilution provisions contained in the applicable award, which provisions were triggered as a result of the completion of the Issuer's pro-rata distribution of a portion of the outstanding shares of Technip Energies N.V. to the Issuer's shareholders (the "Spin-off") on February 16, 2021.

Remarks:

	/s/ Lisa P. Wang, Attorney-In-Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did TechnipFMC (FTI) executive Jonathan Landes report?

Jonathan Landes reported option exercises, share sales, and a gift. He exercised employee stock options for 18,190 Ordinary Shares, sold 116,194 shares in open‑market transactions at prices around the low‑$60s, and made a bona fide gift of 20,768 shares, all on March 9, 2026.

How many TechnipFMC (FTI) shares did Jonathan Landes sell and at what prices?

Landes sold 116,194 Ordinary Shares in three tranches. The weighted average prices were $61.26, $62.13, and $63.13, with individual trades occurring within narrow ranges around each level, as detailed in the weighted‑average footnotes.

What stock options did Jonathan Landes exercise in this TechnipFMC (FTI) Form 4?

He exercised two employee stock option grants into Ordinary Shares. The exercises covered 7,317 shares at an exercise price of $25.24 and 10,873 shares at $21.10, totaling 18,190 shares, with the underlying options expiring in 2027 and 2028 respectively.

Did Jonathan Landes retain any TechnipFMC (FTI) shares after these transactions?

Yes, Landes retained a direct ownership stake after the trades. Following the option exercises, open‑market sales totaling 116,194 shares, and a gift of 20,768 shares, his reported direct holdings stand at 50,588 Ordinary Shares of TechnipFMC plc.

Were Jonathan Landes’s TechnipFMC (FTI) share sales under a Rule 10b5-1 plan?

The transactions were carried out under a pre‑arranged trading plan. The filing states that all sales and the exercise of stock options were effected pursuant to a Rule 10b1-5 trading plan adopted by Landes on December 3, 2025.

Did the TechnipFMC (FTI) Form 4 include any gifts of shares by Jonathan Landes?

Yes, the filing reports a bona fide gift of shares. On March 9, 2026, Landes transferred 20,768 Ordinary Shares as a gift at a reported price of $0.00, indicating no consideration was received for this disposition.